Clinical studies have also reported beneficial effects of resistant starch on CRC risk through reduction in the percent of mitotic cells in the crypt as well as overexpression of genes, CDK4 and GADD45A, which are associated with reduction in cell proliferation and increased genomic stability [33]. This evidence concerns the gene CDK4 and colorectal carcinoma.